Skip to content
Review Open access

Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression.

Sep 2026 · Vaccine · Vol 92, pp. 129163 · 0 citations · 21 references
Medicine

TL;DR

Higher country-level influenza vaccination coverage was inversely associated with mortality and DALY burden among adults aged ≥55 years and should be interpreted as hypothesis-generating population-level associations rather than causal effects.

Abstract

Background

Few studies have examined whether country-level seasonal influenza vaccination coverage is associated with population health burden. We assessed the associations of influenza vaccination coverage with all-cause mortality and disability-adjusted life years (DALYs) across countries participating in the Survey of Health, Ageing and Retirement in Europe (SHARE).

Methods

We conducted an ecological panel analysis using SHARE Waves 8 (2019-2020) and 9 (2021-2022) across participating EU/EEA countries, Switzerland, and Israel. Survey-weighted vaccination coverage and structural indicators were derived among adults aged ≥55 years. All-cause mortality, all-cause DALYs, lower respiratory tract infection (LRTI) DALYs, and chronic disease-specific DALYs were obtained from the Global Burden of Disease database for the same age group. Principal component analysis (PCA) was performed on the pooled country-season dataset to summarize correlated structural covariates. Associations were estimated using linear mixed-effects models with country-specific random intercepts.

Results

Mean vaccination coverage increased from 34.5% to 47.6% but remained below the EU target of 75% in many countries. After adjustment for period and PCA-derived covariates, a 1-percentage-point higher vaccination coverage was associated with 14.9 fewer all-cause deaths per 100,000 adults aged ≥55 years (95% CI: -22.8 to -7.1), 328.1 fewer all-cause DALYs per 100,000 (95% CI: -480.4 to -175.8), and 6.3 fewer LRTI DALYs per 100,000 (95% CI: -10.6 to -2.0). Subgroup-specific vaccination coverage was also inversely associated with diabetes DALYs (-12.1; 95% CI: -20.3 to -3.8).

Conclusions

In this two-period ecological analysis, higher country-level influenza vaccination coverage was inversely associated with mortality and DALY burden among adults aged ≥55 years. These findings should be interpreted as hypothesis-generating population-level associations rather than causal effects.

Read PDF

Similar papers

Sep 2026

Influenza vaccine effectiveness against influenza-related medical visits, hospitalization and death among adults aged 65 years and older in Taiwan: interim 2024-2025 season result using standard-dose inactivated influenza vaccine.

BACKGROUND The 2024-2025 influenza season in Taiwan was notably more severe than the prior season, with severe cases increasing from 1433 to 2215 and deaths increasing from 297 to 545. Vaccination coverage among adults aged ≥65 years also declined from 53.6% to 48.1%. All government-funded vaccines in the 2024-2025 sea...

Tsung-Pei Tsou, Yi-Ting Huang, Chieh-Yu Lin et al. · 0 citations
Open access Sep 2026

Assessing the impact of routine malaria vaccination on total disease burden in Cameroon: a nationwide difference‑in‑differences analysis using health district surveillance data (2023–2025)

Cameroon introduced the RTS, S/AS01 malaria vaccine into routine expanded immunisation (EPI) in 2024, targeting 42 priority health districts. We assessed changes in total malaria burden between intervention and non-intervention districts over 2023–2025. We conducted a retrospective, quasi-experimental, ecological longi...

C. Bekolo, Nina Ngouenko, Esther Laura Nyame Dipepa Nwall et al. · 0 citations
Open access Sep 2026

Real-World Effectiveness of Influenza Vaccination Against Medically Attended Influenza and Severe Outcomes Among Older Adults in Yichang, China: A Multi-Season Population-Based Cohort Study

Background/Objectives: Real-world evidence on influenza vaccine effectiveness (VE) against severe outcomes among older adults in China remains limited. We evaluated influenza vaccination against medically attended influenza, influenza hospitalization, and influenza-related intensive care unit (ICU) admission among adul...

Guan-Qi Wang, Hong Cao, Yi Yan et al. · 0 citations
Open access Aug 2026

Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe, 2015/16-2024/25.

Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.

Diogo F. P. Marques, Angela M. C. Rose, S. Monge et al. · 0 citations
Open access Oct 2026

Potential impact of changes in influenza vaccination coverage and effectiveness on pediatric influenza burden in the United States, 2022/23-2024/25

Background and Objectives: Influenza vaccination has a strong safety record and is effective in reducing pediatric influenza-associated morbidity and mortality. However, pediatric vaccination coverage (VC) has declined since the 2019/20 influenza season in the United States. We estimated the impact of increased vaccine...

S. E. Morris, S. Mathis, J. Chung et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.